|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 5/10 | (2006.01) |
| A61K 35/17 | (2015.01) | ||
| A61K 35/545 | (2015.01) |
| (11) | Number of the document | 2961831 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14756894.3 |
| Date of filing the European patent application | 2014-02-26 | |
| (97) | Date of publication of the European application | 2016-01-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-10 |
| (46) | Date of publication of the claims translation | 2020-11-10 |
| (86) | Number | PCT/US2014/018667 |
| Date | 2014-02-26 |
| (87) | Number | WO 2014/134165 |
| Date | 2014-09-04 |
| (30) | Number | Date | Country code |
| 201361769543 P | 2013-02-26 | US |
| (72) |
BRENTJENS, Renier, J., US
JACKSON, Hollie, J., US
|
| (73) |
Memorial Sloan Kettering Cancer Center,
1275 York Avenue, New York, NY 10021,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, skirti imunoterapijai |
| COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-01-20 | 12 | 289.00 EUR |
| 2026-02-26 |